Two Sigma Advisers’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-12,300
Closed -$16K 2741
2022
Q3
$16K Buy
+12,300
New +$26.8K ﹤0.01% 2457
2022
Q2
Sell
-11,000
Closed -$76K 2930
2022
Q1
$76K Sell
11,000
-1,200
-10% -$12.7K ﹤0.01% 2541
2021
Q4
$194K Buy
+12,200
New +$244K ﹤0.01% 2295

Other funds holding RNLX

Two Sigma Advisers's RNLX Position: Q4 2022 in Review

Two Sigma Advisers sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2022, closing a stake of 12,300 shares — an estimated $16K sold.

Two Sigma Advisers first reported a position in RNLX in Q4 2021 and held it in 3 quarters. The position peaked at $194K in Q4 2021. 21 funds tracked by Wall St. Rank hold RNLX as of Q4 2022.

  • Two Sigma Advisers reported no remaining Renalytix plc American Depositary Shares position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 12,300 Renalytix plc American Depositary Shares shares in Q4 2022, an estimated $16K.
  • Two Sigma Advisers first reported a position in Renalytix plc American Depositary Shares in Q4 2021 and held it in 3 quarters.
  • Two Sigma Advisers's Renalytix plc American Depositary Shares position peaked at $194K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2022.

Based on Two Sigma Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.